Product Details for ANDA 060429
SUMYCIN (TETRACYCLINE HYDROCHLORIDE)
100MG
Marketing Status: Discontinued
125MG
Marketing Status: Discontinued
250MG
Marketing Status: Discontinued
500MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
Active Ingredient: TETRACYCLINE HYDROCHLORIDE
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
SUMYCIN (TETRACYCLINE HYDROCHLORIDE)
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
125MG
Marketing Status: Discontinued
Active Ingredient: TETRACYCLINE HYDROCHLORIDE
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
SUMYCIN (TETRACYCLINE HYDROCHLORIDE)
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
250MG
Marketing Status: Discontinued
Active Ingredient: TETRACYCLINE HYDROCHLORIDE
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
SUMYCIN (TETRACYCLINE HYDROCHLORIDE)
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG
Marketing Status: Discontinued
Active Ingredient: TETRACYCLINE HYDROCHLORIDE
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: SUMYCIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060429
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information